RSV vaccines off to a sluggish start in US this season, with volumes behind 2023

This sea­son’s up­take of RSV vac­cines in the US has been slow­er than ex­pect­ed, ac­cord­ing to Wall Street an­a­lysts track­ing pre­scrip­tions, and ap­pears to be …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.